SBI Mutual Fund on Friday bought additional shares of pharmaceutical company Alkem Laboratories for Rs 300 crore through an open market transaction. According to the block deal data available on the National Stock Exchange, SBI Mutual Fund acquired 6.41 lakh shares or 0.54% stake in Mumbai-headquartered Alkem Laboratories.
The shares were picked up at an average price of Rs 4,680 apiece, taking the transaction value to Rs 300.32 crore.
After the stake buy, SBI Mutual Fund's holding in Alkem rose to 2.7% from 2.16%.
Meanwhile, Samprada & Nanhamati Singh Family Trust (related to Alkem promoters) offloaded the same number of shares of the company, showed the data on the NSE.
On Friday, shares of Alkem Laboratories fell 2.54% to close at Rs 4,600.05 apiece on the NSE.
RECOMMENDED FOR YOU
HDFC Mutual Fund Buys Sundaram Fasteners Shares For Rs 137 Crore
Jun 27, 2025
Indogulf Cropsciences IPO: Anchor Investors Invest Rs 58 Crore
Jun 25, 2025
Vishal Mega Mart Bulk Deal: SBI, Kotak, HDFC Mutual Funds Among Top Buyers
Jun 17, 2025
Reliance Industries Sells Asian Paints Shares Worth Rs 7,703 Crore, SBI Mutual Fund Sole Buyer
Jun 12, 2025
POPULAR